Exercise Mode and Acute Bone Resorption
Comparison of Exercise Mode on Disruptions in Calcium Homeostasis
2 other identifiers
interventional
9
1 country
1
Brief Summary
Endurance exercise is often recommended to improve cardiometabolic health and maintain bone health throughout life and to prevent osteoporotic fracture. However, there is evidence to suggest that bone does not always adapt in the way that is expected, and that endurance exercise may lead to bone loss under certain conditions. Disruptions in calcium homeostasis during exercise may explain this observation, and preliminary data suggests that the mode of exercise (i.e., cycling versus treadmill) may result in different magnitudes of change in bone biomarkers. The purpose of this study is to determine if mode of exercise results in a differential bone biomarker response to an acute exercise bout in older Veterans. Blood samples will be collected before, during, and after 2 acute exercise bouts: 1) brisk treadmill walking; and 2) vigorous stationary cycling. Bouts will be matched for relative intensity and duration. This data will be used to develop future exercise interventions in older Veterans aimed at preserving both cardiometabolic and bone health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2021
CompletedFirst Posted
Study publicly available on registry
March 25, 2021
CompletedStudy Start
First participant enrolled
October 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedResults Posted
Study results publicly available
July 20, 2025
CompletedJuly 20, 2025
July 1, 2025
2.7 years
March 22, 2021
June 5, 2025
July 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
C-telopeptide of Type I Collagen (CTX) Change
CTX is a blood marker of bone resorption. Reference range is 0.1-0.8 ng/mL with lower concentrations suggesting less bone resorption.
Before to up to 48 hours after acute exercise bout
Secondary Outcomes (1)
Procollagen of Type I N-terminal Propeptide (P1NP) Change
Before to up to 48 hours after acute exercise bout
Study Arms (2)
Stationary Cycling
EXPERIMENTALAll participants will complete one, 60-minute bout of stationary cycling
Treadmill Walking
EXPERIMENTALAll participants will complete one, 60-minute bout of treadmill walking
Interventions
Eligibility Criteria
You may qualify if:
- Healthy older (60+ y) Veteran women and men will be eligible to participate
- All volunteers must be accustomed to performing 60 minutes of vigorous cycling and treadmill exercise
You may not qualify if:
- impaired renal function, defined as an eGRF of \<60 mL/min/1.73m2;(Florkowski and Chew-Harris 2011)
- hepatobiliary disease, defined as liver function tests (AST, ALT) \>1.5 times the upper limit of normal
- thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH) \<0.5 or \>5.0 mU/L
- serum Ca \<8.5 or \>10.3 mg/dL; 5) serum 25(OH)D \<20 ng/mL
- uncontrolled hypertension, defined as resting systolic blood pressure (BP) \>150 mmHg or diastolic BP \>90 mmHg
- history of type 1 or type 2 diabetes
- cardiovascular disease; defined as subjective or objective indicators of ischemic heart disease (e.g., angina, ST segment depression) or serious arrhythmias at rest or during the graded exercise test (GXT)
- volunteers who have a positive GXT can be re-considered after follow-up evaluation, which must include diagnostic testing (e.g., stress echocardiogram or thallium stress test) with interpretation by a cardiologist
- anemia, defined as a serum hemoglobin \<12.1 g/dL for women and \<14.3 g/dL for men
- fracture in the past 6 months
- current diagnosis or symptoms of COVID-19
- In the event of abnormal BP, live function, TSH, 25(OH)D, or hemoglobin values, volunteers can be reassessed, including after appropriate follow-up evaluation and treatment by a primary care provider
- Those who have experienced symptoms of COVID-19 or have been formally diagnosed will be allowed to participate once symptoms have resolved and they are approved to return to exercise by their primary care provider
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, 80045-7211, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Sarah Wherry
- Organization
- VA Eastern Colorado Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah J Wherry, PhD
Rocky Mountain Regional VA Medical Center, Aurora, CO
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2021
First Posted
March 25, 2021
Study Start
October 8, 2021
Primary Completion
June 30, 2024
Study Completion
September 30, 2024
Last Updated
July 20, 2025
Results First Posted
July 20, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share